Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes

Alexander Spratt, Lauren S. Blieden, Sander Dubovy, Audina Berrocal, Richard K Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.

Original languageEnglish (US)
JournalJournal of Glaucoma
DOIs
StateAccepted/In press - Aug 26 2016

Fingerprint

Retinal Diseases
Aptitude
Membranes
Lasers
Therapeutics
Bevacizumab
Surgeons

ASJC Scopus subject areas

  • Medicine(all)
  • Ophthalmology

Cite this

Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes. / Spratt, Alexander; Blieden, Lauren S.; Dubovy, Sander; Berrocal, Audina; Lee, Richard K.

In: Journal of Glaucoma, 26.08.2016.

Research output: Contribution to journalArticle

@article{b48e21612b7a4283bc15b83b86438ca0,
title = "Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes",
abstract = "PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.",
author = "Alexander Spratt and Blieden, {Lauren S.} and Sander Dubovy and Audina Berrocal and Lee, {Richard K}",
year = "2016",
month = "8",
day = "26",
doi = "10.1097/IJG.0000000000000543",
language = "English (US)",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes

AU - Spratt, Alexander

AU - Blieden, Lauren S.

AU - Dubovy, Sander

AU - Berrocal, Audina

AU - Lee, Richard K

PY - 2016/8/26

Y1 - 2016/8/26

N2 - PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.

AB - PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.

UR - http://www.scopus.com/inward/record.url?scp=84984662508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984662508&partnerID=8YFLogxK

U2 - 10.1097/IJG.0000000000000543

DO - 10.1097/IJG.0000000000000543

M3 - Article

C2 - 27571445

AN - SCOPUS:84984662508

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

ER -